Biotest Aktiengesellschaft reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was EUR 158 million compared to EUR 137.2 million a year ago. Net income was EUR 22.2 million compared to net loss of EUR 15 million a year ago. Basic earnings per share from continuing operations was EUR 0.55 compared to basic loss per share from continuing operations of EUR 0.39 a year ago.
For the six months, sales was EUR 275.3 million compared to EUR 253.1 million a year ago. Net income was EUR 1.7 million compared to net loss of EUR 19.9 million a year ago. Basic earnings per share from continuing operations was EUR 0.03 compared to basic loss per share from continuing operations of EUR 0.5 a year ago.